Rev Group, Inc. appointed global business executive and board director Maureen O’Connell as an independent member of its board of directors, effective Aug. 25.
She succeeds Justin Fish, who has resigned after seven years as a board director. O’Connell will sit on the Nomination and Governance Committee.
“On behalf of the Board of Directors, I want to thank Justin for his valuable contributions to Rev Group over the past seven years,” said Paul Bamatter, Rev Group board chairman. “We are delighted to announce Maureen’s election to the board. She is a seasoned business leader with experience in finance, operations, and board oversight of companies across multiple industries. Maureen’s diversity of experience will help broaden the skills of the current board and be invaluable to REV Group as it continues to execute on its vision.”
In addition to Rev Group, O’Connell is a board member and audit chair for Northwest Healthcare Properties REIT, a board member and audit chair for HH Global and a board member for Arix Bioscience plc.
O’Connell also is a board member and audit chair for Acacia Research, serving as audit chair since 2019, chairman from May 2019 until November 2022, and lead director since July 2023.
O’Connell’s career spans 30 years of progressive experience in finance and operations management at several global public companies. She was executive vice president and chief financial officer of Scholastic Corp., and was responsible for finance, operations, supply chain, technology, human resources and legal at the company. Before this, she served as president and chief operating officer at Gartner and chief financial officer of Barnes & Noble.
O’Connell is a NACD-certified director.
